QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) All Versions of this Article: dmd.104.002410v1 33/4/489    most recent Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Ma, X. Articles by Gonzalez, F. J. Search for Related Content PubMed PubMed Citation Articles by Ma, X. Articles by Gonzalez, F. J.

METABOLISM OF MELATONIN BY HUMAN CYTOCHROMES P450

Laboratory of Metabolism, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland (X.M., K.W.K., F.J.G.); and Institute of Pharmacology, 1^st Faculty of Medicine, Charles University, Praha, Czech Republic (J.R.I.)

In humans, the pineal hormone melatonin (MEL) is principally metabolized to 6-hydroxymelatonin (6-HMEL), which is further conjugated with sulfate and excreted in urine. MEL O-demethylation represents a minor reaction. The exact role of individual human cytochromes P450 (P450s) in these pathways has not been established. We used a panel of 11 recombinant human P450 isozymes to investigate for the first time the 6-hydroxylation and O-demethylation of MEL. CYP1A1, CYP1A2, and CYP1B1 all 6-hydroxylated MEL, with CYP2C19 playing a minor role. These reactions were NADPH-dependent. CYP2C19 and, to some extent CYP1A2, O-demethylated MEL. The K_m (µM) and V_max (k_cat, pmol min^-1 pmol^-1 P450) for 6-hydroxylation were estimated as 19.2 ± 2.01 and 6.46 ± 0.22 (CYP1A1), 25.9 ± 2.47 and 10.6 ± 0.32 (CYP1A2), and 30.9 ± 3.76 and 5.31 ± 0.21 (CYP1B1). These findings confirm the suggestion of others that CYP1A2 is probably the foremost hepatic P450 in the 6-hydroxylation of MEL and a single report that CYP1A1 is also able to mediate this reaction. However, this is the first time that CYP1B1 has been shown to 6-hydroxylate MEL. The IC₅₀ for the CYP1B1-selective inhibitor (E)-2,4,3',5'-tetramethoxystilbene was estimated to be 30 nM for MEL 6-hydroxylation by recombinant human CYP1B1. Comparison of brain homogenates from wild-type and cyp1b1-null mice revealed that MEL 6-hydroxylation was clearly mediated to a significant degree by CYP1B1. CYP1B1 is not expressed in the liver but has a ubiquitous extrahepatic distribution, and is found at high levels in tissues that also accumulate either MEL or 6-HMEL, such as intestine and cerebral cortex, where it may assist in regulating levels of MEL and 6-HMEL.

This article has been cited by other articles:

				S.-Y. Chang, C. Chen, Z. Yang, and A. D. Rodrigues Further Assessment of 17{alpha}-Ethinyl Estradiol as an Inhibitor of Different Human Cytochrome P450 Forms in Vitro Drug Metab. Dispos., August 1, 2009; 37(8): 1667 - 1675. [Abstract] [Full Text] [PDF]

				L. Carvalho, C Gorenstein, R Moreno, C Pariante, and R. Markus Effect of antidepressants on melatonin metabolite in depressed patients J Psychopharmacol, May 1, 2009; 23(3): 315 - 321. [Abstract] [PDF]

				M. Mise, T. Hashizume, and S. Komuro Characterization of Substrate Specificity of Dog CYP1A2 Using CYP1A2-Deficient and Wild-Type Dog Liver Microsomes Drug Metab. Dispos., September 1, 2008; 36(9): 1903 - 1908. [Abstract] [Full Text] [PDF]

				X. Ma, C. Chen, K. W. Krausz, J. R. Idle, and F. J. Gonzalez A Metabolomic Perspective of Melatonin Metabolism in the Mouse Endocrinology, April 1, 2008; 149(4): 1869 - 1879. [Abstract] [Full Text] [PDF]

				W. Hu, C. Sorrentino, M. S. Denison, K. Kolaja, and M. R. Fielden Induction of Cyp1a1 Is a Nonspecific Biomarker of Aryl Hydrocarbon Receptor Activation: Results of Large Scale Screening of Pharmaceuticals and Toxicants in Vivo and in Vitro Mol. Pharmacol., June 1, 2007; 71(6): 1475 - 1486. [Abstract] [Full Text] [PDF]

				T. W. Fischer, T. W. Sweatman, I. Semak, R. M. Sayre, J. Wortsman, and A. Slominski Constitutive and UV-induced metabolism of melatonin in keratinocytes and cell-free systems FASEB J, July 1, 2006; 20(9): 1564 - 1566. [Abstract] [Full Text] [PDF]

				Y.-J. Chun, S.-K. Lee, and M. Y. Kim MODULATION OF HUMAN CYTOCHROME P450 1B1 EXPRESSION BY 2,4,3',5'-TETRAMETHOXYSTILBENE Drug Metab. Dispos., December 1, 2005; 33(12): 1771 - 1776. [Abstract] [Full Text] [PDF]